
Orion Tong
Articles
-
Nov 6, 2024 |
biorxiv.org | Esther Ng |Orion Tong |Chelsea Taylor |Robert Watson
AbstractCD8+ T cells play a central role in the cancer response to immune checkpoint blockade (ICB) treatment, with activity predicated upon antigen recognition by the associated T cell receptor (TCR) repertoire. The contribution of genetic variation to this in cancer treatment is under-explored.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →